CMG Pharmaceutical Co (XKRX:058820) Ending Cash Position : ₩3,241 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is CMG Pharmaceutical Co Ending Cash Position?

CMG Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩3,241 Mil.

CMG Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2023 (₩5,911 Mil) to Dec. 2023 (₩1,243 Mil) but then increased from Dec. 2023 (₩1,243 Mil) to Mar. 2024 (₩3,241 Mil).

CMG Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (₩4,759 Mil) to Dec. 2022 (₩4,456 Mil) and declined from Dec. 2022 (₩4,456 Mil) to Dec. 2023 (₩1,243 Mil).

CMG Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for CMG Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMG Pharmaceutical Co Ending Cash Position Chart

CMG Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

18,570.59

8,044.24

4,759.02

4,455.80

1,242.52

CMG Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															21,042.39	8,349.85	5,910.76	1,242.52	3,241.33

CMG Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CMG Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4455.796	+	-3213.276
	=	1,243

CMG Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1242.52	+	1998.811
	=	3,241

CMG Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of CMG Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

CMG Pharmaceutical Co (XKRX:058820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Cheongdam-dong 18-20, No. B01, Gangnam-gu, Seoul, KOR, 135-949

Website

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co Ltd is the sole pharmaceutical company and an affiliate company of CHA Health Systems. CHA Health Systems are integrated systems which include medical school, pharmacy school, research institutes, general hospitals and many affiliates which are related to stem cell research, biotechnology and pharmaceutical business all over the world.

CMG Pharmaceutical Co (XKRX:058820) Headlines

No Headlines